Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells

Cancer

Volumn 120, Issue 3, 2014, Pages 363-372

  Li, Xiang Ping ^a   Wang, Lu ^a   Tian, Wen Dong ^a   Xu, Xia ^a   Nie, Biao ^a   Lu, Juan ^a   Liu, Xiong ^a   Zhang, Bao ^a   Dong, Qi ^b   Sunwoo, John B ^c   Li, Gang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

epithelial mesenchymal transition; Epstein Barr virus; metastasis; microRNA; nasopharyngeal carcinoma

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; MICRORNA 200A; MICRORNA 200B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NASOPHARYNX CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; UPREGULATION;

EPITHELIAL-MESENCHYMAL TRANSITION; EPSTEIN-BARR VIRUS; METASTASIS; MICRORNA; NASOPHARYNGEAL CARCINOMA;

CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84892921109     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28418     Document Type: Article

References (37)

1. McDermott AL, Dutt SN, Watkinson JC,. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 2001; 26: 82-92.
2. Yu MC, Yuan JM,. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002; 12: 421-429.
3. Young LS, Rickinson AB,. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004; 4: 757-768.
4. Shair KH, Schnegg CI, Raab-Traub N,. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. Cancer Res. 2009; 69: 5734-5742.
5. Lin JC, Liao SK, Lee EH, et al. Molecular events associated with epithelial to mesenchymal transition of nasopharyngeal carcinoma cells in the absence of Epstein-Barr virus genome [serial online]. J Biomed Sci. 2009; 16: 105.
6. Horikawa T, Yang J, Kondo S, et al. C Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007; 67: 1970-1978.
7. Kong QL, Hu LJ, Cao JY, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma [serial online]. PLoS Pathog. 2010; 6: e1000940.
8. Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y, Pagano JS,. Epstein-Barr virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer. 2011; 104: 1160-1167.
9. De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol. 2008; 130: 481-494.
10. Voulgari A, Pintzas A,. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 2009; 1796: 75-90.
11. Liebowitz D,. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol. 1994; 21: 376-381.
12. Chan AT,. Nasopharyngeal carcinoma. Ann Oncol. 2010; 21 (suppl 7): vii308-vii312.
13. Murakami M, Lan K, Subramanian C, Robertson ES,. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol. 2005; 79: 1559-1568.
14. Kaul R, Murakami M, Choudhuri T, Robertson ES,. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol. 2007; 81: 10352-10361.
15. Lu J, He ML, Wang L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 2011; 71: 225-233.
16. Gullo C, Low WK, Teoh G,. Association of Epstein-Barr Virus with nasopharyngeal carcinoma and current status of development of cancer-derived cell lines. Ann Acad Med Singapore. 2008; 37: 769-777.
17. Cao JY, Mansouri S, Frappier L,. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J Virol. 2012; 86: 382-394.
18. Valentine R, Dawson CW, Hu C, et al. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol Cancer. 2010; 9: 1
19. Sivachandran N, Sarkari F, Frappier L,. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 2008; 4: e1000170.
20. Lou P, Chen W, Sheen T, Ko J, Hsu M, Wu J,. Expression of E-cadherin/catenin complex in nasopharyngeal carcinoma: correlation with clinicopathological parameters. Oncol Rep. 1999; 6: 1065-1071.
21. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW,. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol. 1999; 30: 458-46621.
22. Spaderna S, Schmalhofer O, Wahlbuhl M, et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res. 2008; 68: 537-544.
23. Drake JM, Strohbehn G, Bair TB, Moreland JG, Henry MD,. ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol Biol Cell. 2009; 20: 2207-2217.
24. Vandewalle C, Van Roy F, Berx G,. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci. 2009; 66: 773-787.
25. Dohadwala M, Wang G, Heinrich E, et al. The role of ZEB1 in the inflammation-induced promotion of EMT in HNSCC. Otolaryngol Head Neck Surg. 2010; 142: 753-759.
26. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008; 68: 7846-7854.
27. Sass S, Dietmann S, Burk UC, et al. MicroRNAs coordinately regulate protein complexes. BMC Syst Biol. 2011; 25; 5: 136.
28. Scheel C, Eaton EN, Li SH, et al. Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell. 2011; 145: 926-940.
29. Sánchez-Tillõ E, Lázaro A, Torrent R, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 2010; 29: 3490-3500).
30. Brabletz S, Brabletz T,. The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? EMBO Rep. 2010; 11: 670-677
31. Xia H, Cheung WK, Sze J, et al. miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem. 2010; 285: 36995-37004
32. Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011; 22: 1686-1698.
33. Zhao J, Jin H, Cheung KF, et al. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer. Cancer. 2012; 118: 924-936.
34. Miyazono K,. Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85: 314-323.
35. Flavell JR, Baumforth KR, Wood VH, et al. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Blood. 2008; 111: 292-301.
36. Wood VH, O'Neil JD, Wei W, et al. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene. 2007; 26: 4135-4147
37. Frappier L,. Role of EBNA1 in NPC tumourigenesis. Semin Cancer Biol. 2012; 22: 154-161.